3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Colorectal Neoplasms
3
Osteosarcoma
2
Neoplasms
2
Wilms Tumor
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Rectal Cancer Patients
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasm Metastasis
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Hepatoblastoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Advanced Rectal Cancer
1
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Sunitinib
2
Everolimus
2
sargramostim
1
montanide ISA 51
1
lutetium Lu 177 dotatate
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
X-Rays
1
Temozolomide
1
Phantoms, Imaging
1
Octreotide
1
Methods
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
irinotecan sucrosofate
×
90 days
×
Clear all
No trials found.